Life Sciences
Research on life sciences detailed by scientists at Kyushu University, Medical Department
Published in Cardiovascular Business Week, March 3rd, 2009
"Etomidate minimally influences hemodynamics at a standard induction dose in young healthy patients, but can cause significant systemic hypotension at higher doses for induction or electroencephalographic burst suppression (i.e., cerebral protection) in patients with advanced age or heart disease, and during cardiopulmonary bypass. However, less is known about its action on systemic resistance arteries," investigators in Fukuoka, Japan report.
"Using an isometric force recording method and fura-2-fluorometry, we investigated the action of etomidate on vascular reactivity in small mesenteric arteries from Young (7-8 wk old, n = 179) and aged (96-98 wk old, n = 10) rats....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Acusphere Inc.
Acusphere Announces Change In Imagify Regulatory Strategy and Deferral of Near-Term Contractual Cash Payments - Allscripts
Pee Dee Cardiology Selects Allscripts Professional Electronic Health Record and Practice Management Solution - American Heart Association and AstraZeneca
AstraZeneca, American Heart Association Pay It Forward to the City of New Orleans with Donation to Rebuild City Walking Path - Apple Valley Medical Center
Heart Awareness Evening Scheduled for February 26 at Apple Valley Medical Center - Atherotech, Inc.
VAP Test Demonstrates Value of Fish Oil in Reducing Heart Risk for Super Bowl Champs - AtriCure, Inc.
AtriCure Reports Fourth Quarter and Full Year 2008 Financial Results - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
